Skip to content

REMEDIUM

Active Risk: Limited partnershipfounded 2019active for 7 yearsPilkemseweg 21, 8900 YpresKBO/BCE: BE 0736.569.203
REMEDIUM
Follow ReportCompare

Board

Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each manager alone
deed of 29-10-2019

Office holders in the KBO →

Mandates through the years

1 name

Manager
Earlierend not dated
Mandates as a list
    • Manager, appointed by deed of 29-10-2019, last mentioned in 2019

Control

Founder
This company
REMEDIUM

Capital

Capital
€100
Shares
100
Contribution per share
€1
Source
deed of 29-10-2019

Articles of association

deed of 29-10-2019 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
“Vaste vertegenwoordiger rechtspersoon-zaakvoerder, uitdrukkelijk akkoord bestuurde vennootschap”
Financial yearThe company draws up its annual accounts over this twelve-month period.
From 1 October to 30 September
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Third Tuesday of March at 19:00

Founder

At incorporation deed of 29-10-2019 ↗
  • gecommanditeerde vennoot

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what became of the directors' other companies.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file

We would like to set cookies. That happens only with your consent. What we measure